Q
BMY icon

QVR’s Bristol-Myers Squibb BMY Stock Holding History

QVR’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,811
Closed -$474K – 25
2026
Q1 		$474K Sell
7,811
-6,709
-46% -$391K 0.02% 91
2025
Q4 		$783K Buy
+14,520
New +$699K 0.04% 52
2024
Q2 		– Sell
-6,610
Closed -$358K – 5
2024
Q1 		$358K Buy
+6,610
New +$337K 0.06% 25
2023
Q1 		– Sell
-145
Closed -$10.4K – 31
2022
Q4 		$10.4K Buy
+145
New +$10.9K ﹤0.01% 191
2021
Q4 		– Sell
-4,246
Closed -$251K – 62
2021
Q3 		$251K Buy
+4,246
New +$280K 0.02% 278
2021
Q1 		– Sell
-1,753
Closed -$109K – 248
2020
Q4 		$109K Buy
+1,753
New +$108K 0.01% 100

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

QVR's BMY Position: Q2 2026 in Review

QVR sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 7,811 shares — an estimated $474K sold.

QVR first reported a position in BMY in Q4 2020 and held it in 6 quarters. The position peaked at $783K in Q4 2025. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • QVR reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • QVR sold 7,811 Bristol-Myers Squibb shares in Q2 2026, an estimated $474K.
  • QVR first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 6 quarters.
  • QVR's Bristol-Myers Squibb position peaked at $783K in Q4 2025.
  • 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on QVR's 13F filing for Q2 2026.